Lead sponsor
Eastern Virginia Medical School
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
1
Trials led
0
Ongoing
44
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 DiabetesHbA1c ≤10%Ph 2Unknown44